HOME >> MEDICINE >> NEWS
Novel Imaging Agent Developed By Penn Researchers Provides Insight Into Brain's Message Delivery System

at are linked to dopamine changes."

Dopamine transporters are protein complexes ocated at the presynaptic (forepart) of dopamine nerve terminals which function to deliver messages to receptors in the brain. A significant reduction in the density of these transporters has been found in postmortem examinations of the brains of Parkinson's and Alzheimer's patients. Thus, measurement of the dopamine transporter with Trodat could be a useful indicator of dopamine neural loss. With advanced radiologic imaging technology, such as single positron emission tomography (SPET) -- which works by emitting photons or light -- Trodat can be a valuable tool for live diagnosis and treatment of illnesses associated with dopamine transporters. Such illnesses include Parkinson's and Alzheimer's, as well as schizophrenia and ALS (Lou Gehrig's disease).

In this study, Trodat was intravenously injected into rats. Trodat displayed specific brain uptake in the rats' striatal region of the brain where dopamine neurons are concentrated. The study's findings strongly support the conclusions that Trodat binds selectively to dopamine transporters in the brain and that it is potentially useful in the assessment of neuron loss. Compared to other imaging agents, Trodat is favorable because it involves very little radioactivity, has a six-hour physical half-life, and is inexpensive. This tracer, coupled with SPET imaging, can provide diagnostic information not attainable by other imaging techniques, including early indications of diseases associated with dopamine changes. Research continues into more advanced stages with goals to ultimately translate findings into clinical applications for patients. Recently, research has progressed to human studies using Trodat.

The University of Pennsylvania Health System is dedicated to developing leaders in science and medicine through education, research, and quality patient ca
'"/>

Contact: Diane Giaccone
dgiaccon@mail.med.upenn.edu
(215) 662-2098
University of Pennsylvania School of Medicine
25-Aug-1998


Page: 1 2 3

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... MD (PRWEB) , ... January 18, 2017 , ... ... of Maryland Fischell Department of Bioengineering are collaborating on a research project focused ... in bioengineering, the project seeks to use nanotechnology to control the disease without ...
(Date:1/18/2017)... CA (PRWEB) , ... January 18, 2017 , ... ... pleased to announce that their Vice President of Franchise Development, Paula Turner Pizarro, ... This award-winning business program, which features the insights of top business leaders from ...
(Date:1/18/2017)... ... 2017 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent Biologics ... at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. , ...
(Date:1/18/2017)... ... ... Floundering on New Year’s resolutions? Need an excuse to get back on track? ... Apple Association agrees and recommends starting each day with apples, a habit proven ... , The U.S. Apple Association – which represents apple growers and producers nationwide – ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers who were ... desire a more intimate review and analysis of its highlights, a novel half-day, complimentary ... offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017 Safe Rx LLC and Good Day ... Loveland, Colorado , today announced the ... Good Day locations.     "Patients with prescriptions ... secure storage," said Milton Cohen , President & ... of a cup of coffee, you can protect your ...
(Date:1/18/2017)... 2017 Invetech, the leading developer of ... therapies , has announced a collaboration agreement with ... starvation" treatments for acute leukemia and other oncology ... Invetech will develop systems to enable the commercial-scale ... technology platform, which uses a novel technology to ...
(Date:1/18/2017)... NEW YORK , January 18, 2017 ... perception of people regarding the use of cannabis both for ... not only are more Americans open to the use of ... and financial sectors. According to Arcview Market Research, the North ... 2016, up 30% from the previous year. The research projects ...
Breaking Medicine Technology:
Cached News: